Manipulation of human ovarian function: physiological concepts and clinical consequences.
about
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian responseThe physiology of follicle selectionIndividualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceClinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysisMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status.Primate follicular development and oocyte maturation in vitro.Anovulation and ovulation induction.Recombinant follitropin alfa/lutropin alfa in fertility treatment.Efficiency of metaphase II oocytes following minimal/mild ovarian stimulation in vitro fertilization.Live imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophoreSystemic concentrations of hormones during the development of follicular waves in mares and women: a comparative studyOvarian follicular development during the use of oral contraception: a reviewIdentification of androgen receptor phosphorylation in the primate ovary in vivo.Mild ovarian stimulation for IVF: 10 years later.Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome.New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control.Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.Involvement of FoxO1 in the effects of follicle-stimulating hormone on inhibition of apoptosis in mouse granulosa cellsGonadotrophins: The future.Intraovarian control of early folliculogenesisComparison of results of cycles treated with modified mild protocol and short protocol for ovarian stimulation.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersAdult hypopituitarism: Are we missing or is it clinical lethargy?Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles.Study of two strategies to induce follicular wave emergence for assisted reproductive treatments (ART)-a preliminary trial.In vitro growth and steroidogenesis of dog follicles are influenced by the physical and hormonal microenvironment.Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction.Survival, growth, and maturation of secondary follicles from prepubertal, young, and older adult rhesus monkeys during encapsulated three-dimensional culture: effects of gonadotropins and insulinLuteal phase estradiol versus luteal phase GnRH antagonist administration: their effects on antral follicular size coordination and basal hormonal levels.Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development.Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response.The potential use of maturation in vitro of human oocytes in low responder patientsRecombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspectiveUse of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study
P2860
Q24289192-1503AA45-A4E4-43EB-9BDA-F6891E9B805FQ24799504-8B177CAE-152A-443D-A056-3DE8CFB10BFDQ26829747-F73C63D3-E97E-4944-8AA0-5D833EDDE0AFQ28293370-1BE997D4-D5F3-4805-9FD2-7C717C8040D7Q30399747-A397B45C-CBFE-472D-92F2-8A53D77E9CB9Q30796722-7FA7F01E-8319-429F-8EAB-7EFF4904F33AQ31827721-57627642-1075-4CFD-93C4-F59D242809BDQ33557700-5FAA8E5A-42A7-4288-A42E-1C3B0263E897Q33598521-03007CFA-EB5A-4C43-AF79-5D996099FB68Q33644799-5BDE4169-85C0-4ED4-82B0-1A7D7F7F2739Q33655088-364E2A58-B114-46D3-9F2F-0EB0C9660A96Q33781591-19AE8E79-FBE5-4C0E-AFAA-F12E705A2BE8Q33898600-B2A00B39-CB9E-4A94-8DA0-DBA1DFBA61C8Q33940461-2F8512BB-C44D-4498-976B-A8A904064BF9Q33943694-94328DBC-E5E2-498A-976E-B73A415398ADQ34139320-7C539E41-94F1-487A-8150-E9AB2585E594Q34196656-676B075F-333A-4BE1-84AE-46B038BAEEFDQ34272169-5E62FD64-64AC-4463-901B-76CE10EE1E90Q34363167-5A6B89A5-5F4A-4A71-A913-92D1314CECC4Q34541556-E485ECCC-C2EA-45A8-ACCC-69574ABF4E59Q34975528-A7AA01F6-415D-4F12-AEF7-EB5EF2796638Q35024088-5A2A8F05-0B3F-4883-BE10-47AE44C7F138Q35100104-A7B56A5F-369B-4774-AD74-9AAECBF670C2Q35108269-262D9447-7BBD-45B0-AF1B-8E4BE9909F9EQ35165880-147B54B1-AB48-48B6-BD91-D044DB41E838Q35171107-DBF085DC-18B5-48D8-ABED-D02F6F6798F9Q35236614-C2B9689C-70BC-45FF-9872-A097EB94F64BQ35632607-9E3BD403-FD92-4375-9EAB-4D74F4F08F4AQ35833291-38C7E532-E58C-4D44-8B4B-C2FD5204B0D3Q35956126-55E20BA5-69FC-48B3-947D-E8A36A3F21AFQ36077008-891CB5A9-3E07-4507-806E-A230F3EE700CQ36136018-06CFDA58-981D-4D24-B2C3-8F8659710B42Q36159645-DA142947-7867-41D9-AEF9-9DB6E6C2DACAQ36195415-7BC61847-7F4B-4602-B250-8F343B4C8B1EQ36268292-2141A15F-F23B-461E-9178-EC056EB3282CQ36269391-E19AB05D-3E26-4A2B-958D-8F9F8EFE933AQ36269497-84EDDFEA-E5B0-4586-AD92-77CD04228304Q36270486-71406385-8ECF-446C-BD11-A2D76FD3FB1EQ36270930-BB5CC310-D3B4-4DB0-8A09-0134D4B98DA5Q36295613-44544F1E-9639-4008-ACFD-1068BAD7A013
P2860
Manipulation of human ovarian function: physiological concepts and clinical consequences.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Manipulation of human ovarian function: physiological concepts and clinical consequences.
@en
type
label
Manipulation of human ovarian function: physiological concepts and clinical consequences.
@en
prefLabel
Manipulation of human ovarian function: physiological concepts and clinical consequences.
@en
P356
P1433
P1476
Manipulation of human ovarian function: physiological concepts and clinical consequences.
@en
P2093
Van Heusden AM
P304
P356
10.1210/ER.18.1.71
P577
1997-02-01T00:00:00Z